Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Debt to Equity (2016 - 2025)

Dare Bioscience (DARE) has disclosed Debt to Equity for 8 consecutive years, with $0.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt to Equity changed N/A year-over-year to $0.0, compared with a TTM value of $0.0 through Sep 2025, changed N/A, and an annual FY2024 reading of -$0.0, changed N/A over the prior year.
  • Debt to Equity was $0.0 for Q3 2025 at Dare Bioscience, up from -$0.01 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.31 in Q1 2021 and bottomed at -$0.01 in Q2 2025.
  • Average Debt to Equity over 3 years is $0.07, with a median of $0.0 recorded in 2024.